Given the predominant localization of FLOT1 in lipid rafts and its regulation of downstream signaling, relying solely on FLOT1 as a single biomarker may not be sufficient to accurately predict the prognosis and response to RT in HNSCC. Here, FLOT1 is linked to head and neck squamous cell carcinoma.